Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ASE Technology Holding Co., Ltd. American Depositary Shares (each representing (NY:ASX)

10.15 -0.08 (-0.73%)
Streaming Delayed Price Updated: 1:18 PM EDT, Jun 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,251,118
Open 9.990
Bid (Size) 10.15 (120)
Ask (Size) 10.16 (158)
Prev. Close 10.23
Today's Range 9.980 - 10.20
52wk Range 6.940 - 12.86
Shares Outstanding 4,408,018,732
Dividend Yield 3.17%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Life360 Enhances Ad Platform With Launch of Place Ads and Uplift, Redefining Real-World Targeting and Measurement
Company introduces breakthrough ad tools that deliver brand messages based on real-world behavior and prove in-store impact with deterministic measurement 
From Life360, Inc.
Via GlobeNewswire
Life360 Announces Closing of Upsized $320 Million Offering of 0.00% Convertible Senior Notes
From Life360, Inc.
Via GlobeNewswire

Performance

YTD
+1.3%
+1.3%
1 Month
+0.7%
+0.7%
3 Month
+6.6%
+6.6%
6 Month
+2.9%
+2.9%
1 Year
-11.2%
-11.2%

More News

Read More
Life360 Announces Pricing of Upsized Convertible Senior Notes Offering
From Life360, Inc.
Via GlobeNewswire
Earnings Scheduled For April 30, 2025
Via Benzinga
P/E Ratio Insights for ASE Technology Holding Co
Via Benzinga
Life360 Proposes Convertible Senior Notes Offering
From Life360, Inc.
Via GlobeNewswire
ASE Announces FOCoS-Bridge With TSV; Latest Package Technology Reduces Power Loss by 3x for Next-Generation AI and HPC Applications
From Advanced Semiconductor Engineering, Inc.
Via Business Wire
5 Undervalued Stocks To Buy On China Tariff Cuts
Via Benzinga
Life360 Reports Record Q1 2025 Results
From Life360, Inc.
Via GlobeNewswire
Alterity Therapeutics Prominently Featured at the International MSA Congress
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Alterity Therapeutics Announces Multiple Oral and Poster Presentations to be Featured at the International MSA Congress
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Alterity Therapeutics Granted U.S. FDA Fast Track Designation for ATH434 to Treat Multiple System Atrophy
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Appendix 4C – Q3 FY25 Quarterly Cash Flow Report
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Alterity Therapeutics Presents ATH434-201 Phase 2 Clinical Trial Results at European MSA Symposium
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
ASE Technology Holding Co Honors Outstanding Suppliers of 2024
From ASE Technology Holding Co., Ltd.
Via Business Wire
Alterity Therapeutics Presents Encouraging New Data from its ATH434 Phase 2 Trial in Multiple System Atrophy at the American Academy of Neurology Annual Meeting
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Alterity Therapeutics to Deliver an Oral Presentation of the Positive ATH434 Phase 2 Trial Results at the American Academy of Neurology Annual Meeting
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
ASE Demonstrates CPO that Improves Energy Efficiency for AI applications
From Advanced Semiconductor Engineering, Inc.
Via Business Wire
Alterity Therapeutics Completes Last Patient Visit in ATH434-202 Open-Label Phase 2 Trial in Multiple System Atrophy
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Oil & Gas Virtual Investor Conference Agenda Announced for March 27th
From Virtual Investor Conferences
Via GlobeNewswire
Life360 Adds a Touch of Kawaii With Tile X Hello Kitty®, a Limited-Edition Collection in Partnership With Sanrio
From Life360, Inc.
Via GlobeNewswire
Life360 Appoints Former Amazon Cybersecurity Lead Vari Bindra as Chief Information Security Officer
From Life360, Inc.
Via GlobeNewswire
Baker Hughes and Woodside Energy Announce Collaboration Framework to Develop Small-Scale Decarbonization Solution Utilizing Net Power Platform
From Baker Hughes
Via GlobeNewswire
Esperion Partners with CSL Seqirus to Commercialize NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) in Australia
From Esperion Therapeutics, Inc.
Via GlobeNewswire
Life360 Reports Record Q4 and FY 2024 Results
From Life360, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is ASE Technology Holding Co., Ltd. American Depositary Shares (each representing publicly traded?
Yes, ASE Technology Holding Co., Ltd. American Depositary Shares (each representing is publicly traded.
What exchange does ASE Technology Holding Co., Ltd. American Depositary Shares (each representing trade on?
ASE Technology Holding Co., Ltd. American Depositary Shares (each representing trades on the New York Stock Exchange
What is the ticker symbol for ASE Technology Holding Co., Ltd. American Depositary Shares (each representing?
The ticker symbol for ASE Technology Holding Co., Ltd. American Depositary Shares (each representing is ASX on the New York Stock Exchange
What is the current price of ASE Technology Holding Co., Ltd. American Depositary Shares (each representing?
The current price of ASE Technology Holding Co., Ltd. American Depositary Shares (each representing is 10.15
When was ASE Technology Holding Co., Ltd. American Depositary Shares (each representing last traded?
The last trade of ASE Technology Holding Co., Ltd. American Depositary Shares (each representing was at 06/13/25 01:18 PM ET
What is the market capitalization of ASE Technology Holding Co., Ltd. American Depositary Shares (each representing?
The market capitalization of ASE Technology Holding Co., Ltd. American Depositary Shares (each representing is 44.76B
How many shares of ASE Technology Holding Co., Ltd. American Depositary Shares (each representing are outstanding?
ASE Technology Holding Co., Ltd. American Depositary Shares (each representing has 45B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.